# Probius DX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/probius-dx

- Industry: Biotechnology
- Headquarters: Fremont, US
- Website: www.probius.bio
- Total disclosed funding: $2.5M
- Latest round: Series A (Dec 1, 2020)
- Investors on record: 9

## About

Based in California, US, and founded in 2016, Probius DX Inc. operates as a biotechnology company that uses artificial intelligence and biology data for biological research and decentralized predictive healthcare. The company was Co-founded by Emmanuel Quevy (CEO), Roger Howe, and Chaitanya Gupta (CTO). In December 2020, Probius DX, Inc. raised Series A funding led by Cota Capital.

The firm offers bioanalytical technology called QES which is combined with artificial intelligence and provides predictive insights into diseases which helps in drug development. The MiniQES bioanalytical platform offered by the firm collects bioanalytical data through MiniQES reader which is an internet of things-based standalone benchtop device, a QES disposable vial that contains sensors that enable quantum electrochemistry, and a bioanalytical cloud service that provides sample classification, biomarker discovery, and analyte quantitation.

## Funding rounds

- Series A, Dec 1, 2020 — Cota Capital
- Seed, Jun 1, 2018, $2.5M — TSVC, Shanda Capital, Social Starts, StartX, Propel(x) Inc., Baidu Ventures, Joyance Partners, Silicon Catalyst

## Investors

- TSVC (https://capitalatlas.ai/funds/tsvc) — Seed
- Shanda Capital — Seed
- Social Starts (https://capitalatlas.ai/funds/social-starts) — Seed
- StartX — Seed
- Propel(x) Inc. — Seed
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Seed
- Joyance Partners (https://capitalatlas.ai/funds/joyance-partners) — Seed
- Silicon Catalyst (https://capitalatlas.ai/funds/silicon-catalyst) — Seed
- Cota Capital (https://capitalatlas.ai/funds/cota-capital) — Series A